Oculocutaneous Albinism Carrier Identifiable With OCT, Regardless of Disease Activity
Patients who are oculocutaneous albinism carriers may exhibit foveal irregularities similar to individuals with partial albinism, a study reports.
Patients who are oculocutaneous albinism carriers may exhibit foveal irregularities similar to individuals with partial albinism, a study reports.
Current treatment options for post-inflammatory hyperpigmentation (PIH), particularly in skin of color, are reviewed.
These OTC skin lightening products containing the active ingredient hydroquinone are not approved and are not generally recognized as safe and effective.
The efficacy and safety of a combination therapy of keratolytic chemical peels with topical keratolytics for improvement in patients with acanthosis nigricans (AN) is assessed.
Disparities in dermatology and the role of ethnic skin centers in addressing these issues are discussed with Angela Lamb, MD.
Mechanisms of postinflammatory hyperpigmentation (PIH) and postinflammatory erythema (PIE) may be closer to being identified.
Consensus statements regarding sunscreen use and the associated risks from sun exposure have been developed by a panel of experts.
Cancer therapies have benefits beyond simple cosmetic repairs, with significant influence on patient outcomes that improve quality of life in many domains including physical, emotional, and social.
The effects of various therapies for telangiectasias and reticular veins are reviewed.
Author reviews a case of prurigo pigmentosa in a patient following the ketogenic diet and outlines a strategy to diagnose and treat this condition.